Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: Recent progress in pathogenesis and management

Table 3 Review of literature on efficacy of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma n (%)

Author, yr	Patients	CR cases	Median FW (yr)	PD	Relapse	Treatment failure1
Hancock et al, 2009	199	92 (46)	ND	ND	ND	25 (13)
Wündisch et al, 2006	193	146 (76)	2.3	0	5 (3.1)	5 (2.6)
Wündisch et al, 2005	120	96 (80)	6.3	0	3 (3.1)	3 (2.5)
Stathis et al, 2009	102	66 (65)	6.3	ND	ND	16 (16)
Kim et al, 2007	99	84 (85)	3.4	0	5 (5.9)	5 (5.1)
Nakamura et al, 2005	96	62 (65)	3.2	7 (7.3)	4 (6.4)	11 (11)
Hong et al, 2006	90	85 (94)	3.8	0	8 (9.4)	8 (8.9)
Fischbach et al, 2004	88	73 (83)	3.8	2 (2.3)	4 (5.5)	6 (6.8)
Nakamura et al, 2008	87	57 (66)	3.5	1 (1.1)	1 (1.8)	2 (2.3)
Savio et al, 2000	76	71 (93)	2.3	0	6 (8.5)	6 (7.9)
Terai et al, 2008	74	66 (89)	3.9	0	3 (4.5)	3 (4.1)
Sumida et al, 2009	66	47 (71)	3.3	0	0	0
Weston et al, 1999	58	40 (69)	1.8	0	0	0
Ono et al, 2010	58	48 (83)	6.3	2 (3.4)	1 (2.1)	3 (5.2)
Andriani et al, 2009	53	42 (79)	5.4	0	9 (21)	9 (17)
Akamatsu et al, 2006	47	30 (64)	3.1	1 (2.1)	1 (3.4)	2 (4.3)
Pinotti et al, 1997	44	30 (68)	1.8	0	2 (6.7)	2 (4.6)
Urakami et al, 2000	44	42 (95)	1.7	0	0	0
Ruskoné-Fourmestraux et al, 2001	44	19 (43)	2.9	1 (2.3)	2 (11)	3 (6.8)
Steinbach et al, 1999	34	14 (41)	3.4	2 (5.9)	0	2 (5.9)
Takenaka et al, 2004	33	26 (79)	ND	0	0	0
Chen et al, 2005	32	24 (75)	5.8	0	3 (13)	3 (9.4)
Lee et al, 2004	28	24 (86)	2.0	0	1 (4.2)	1 (3.6)
Montalban et al, 2005	24	22 (92)	4.6	0	1 (4.5)	1 (4.2)
de Jong et al, 2001	23	13 (57)	3.1	1 (4.3)	0	1 (4.4)
Raderer et al, 2001	22	15 (68)	2.1	0	1 (6.7)	1 (4.6)
Dong et al, 2008	22	13 (59)	1.5	0	0	0
Yamashita et al, 2000	21	14 (67)	0.8	0	0	0
Total of above	1877	1361 (73)	3.3	17 (1.12)	60 (4.93)	118 (6.3)
Nakamura et al[7], 2012	420	323 (77)	6.04	27 (6.4)	10 (3.1)	37 (8.8)

¹Progressive disease (PD) or relapse;

²17/1576 patients;

³60/1203 complete remission (CR) patients (Nakamura et al[7] with modification). FW: Follow-up; ND: Not described.